Cimzia 200 mg lyophilized powder for injection Images
Generic Name: certolizumab
This medication has been identified as Cimzia 200 mg lyophilized powder for injection. It is supplied by UCB, Inc.
Cimzia is used in the treatment of Ankylosing Spondylitis; Crohn's Disease; Crohn's Disease, Maintenance; Crohn's Disease, Active; Non-Radiographic Axial Spondyloarthritis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Cimzia 200 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Cimzia
- Generic Name
- certolizumab
- Strength
- 200 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- UCB, Inc.
- National Drug Code (NDC)
- 50474-0700
More about Cimzia (certolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (86)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
